phenylmethylsulfonyl fluoride has been researched along with levetiracetam in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andres-Mach, M; Chmielewski, J; Florek-Luszczki, M; Kondrat-Wrobel, MW; Luszczki, JJ; Patrzylas, P; Szpringer, M; Zagaja, M; Zaluska, K | 1 |
| Andres-Mach, M; Haratym-Maj, A; Maj, M; Rola, R; Szewczyk, A; Zagaja, M; Łuszczki, JJ | 1 |
2 other study(ies) available for phenylmethylsulfonyl fluoride and levetiracetam
| Article | Year |
|---|---|
Effects of arachidonyl-2'-chloroethylamide (ACEA) on the protective action of various antiepileptic drugs in the 6-Hz corneal stimulation model in mice.
Topics: Acetamides; Animals; Anticonvulsants; Arachidonic Acids; Avoidance Learning; Benzodiazepines; Clobazam; Cornea; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Electroshock; Epilepsy, Complex Partial; Lacosamide; Levetiracetam; Male; Mice; Muscle Strength; Nipecotic Acids; Phenobarbital; Phenylmethylsulfonyl Fluoride; Piracetam; Psychomotor Performance; Receptor, Cannabinoid, CB1; Tiagabine; Valproic Acid | 2017 |
Levetiracetam combined with ACEA, highly selective cannabinoid CB1 receptor agonist changes neurogenesis in mouse brain.
Topics: Animals; Anticonvulsants; Astrocytes; Avoidance Learning; Brain; Disease Models, Animal; Electroshock; Levetiracetam; Male; Mice, Inbred C57BL; Neural Stem Cells; Neurogenesis; Phenylmethylsulfonyl Fluoride; Receptor, Cannabinoid, CB1; Valproic Acid | 2019 |